Asthmatic airway biopsy specimens are more likely to express the IL-4 alternative splice variant IL-4δ2

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 5, 1999, Pages 978-982

  Glare, Eric M ^a   Divjak, Maja ^a   Rolland, Jennifer M ^a   Walters, E Haydn ^a,b  

^a MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Airway tissue; Asthma; Competitive PCR; Endobronchial biopsy; Gene expression; IL 4; IL 4 2; Nasal polyp; Splice variant

Indexed keywords

INTERLEUKIN 4;

ADULT; ARTICLE; ASTHMA; BRONCHUS BIOPSY; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; GENETIC VARIABILITY; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

EID: 0032713057     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70078-3     Document Type: Article

References (30)

1. 1. Borish L, Rosenwasser LJ. Update on cytokines. J Allergy Clin Immunol 1996;97:719-34.
2. 2. Arai N, Nomura D, Villaret D, et al. Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J Immunol 1989;142:274-82.
3. 3. Sorg RV, Enczmann J, Sorg UR, Schneider EM, Wernet P. Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2. Exp Hematol 1993;21:560-3.
4. 4. Alms WJ, Atamas SP, Yurovsky VV, White B. Generation of a variant of human interleukin-4 by alternative splicing. Mol Immunol 1996;33:361-70.
5. 5. Klein SC, Golverdingen JG, van Wichen DF, et al. Expression of two interleukin 4 mRNA isoforms in B lymphoid cells. Cell Immunol 1996;167:259-68.
6. 6. Atamas SP, Choi J, Yurovsky VV, White B. An alternative splice variant of human IL-4, IL-4 delta 2. inhibits IL-4-stimulated T cell proliferation. J Immunol 1996;156:435-41.
7. 7. Arinobu Y, Atamas SP, Otsuka T, et al. Antagonistic effects of an alternative splice variant of human IL-4, IL-482, on IL-4 activities in human monocytes and B cells. Cell Immunol 1999;191:161-7.
8. 8. Tsytsikov VN, Yurovsky VV, Atamas SP, Alms WJ, White B. Identification and characterization of two alternative splice variants of human interleukin-2. J Biol Chem 1996;271:23055-60.
9. 9. Ausubel FA, Brent R, Kinston RE, et al. Current Protocols in Molecular Biology. New York: John Wiley & Sons; 1999.
10. 10. Beach JR, Young CL, Avery AJ, et al. Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response. Thorax 1993;48:239-43.
11. 11. Moqbel R, Ying S, Barkans J, et al. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol 1995;155:4939-47.
12. 12. Dolganov G, Bort S, Lovett M, et al. Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood 1996;87:3316-26.
13. 13. de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 1998;102:165-9.
14. 14. Humbert M, Durham SR, Ying S, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996;154:1497-504.
15. 15. Robinson DS, Hamid Q. Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
16. 16. Ying S, Durham SR, Corrigan CJ, Hamid Q. Kay AB. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokincs in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995;12:477-87.
17. 17. Gelder CM, Thomas PS, Yates DH, Adcock IM, Morrison JF, Barnes PJ. Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction. Thorax 1995;50:1033-7.
18. 18. Marini M, Avoni E, Hollemborg J, Mattoli S. Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients with symptomatic asthma. Chest 1992;102:661-9.
19. 19. Walker C, Bode E, Boer I., Hansel TT, Blaser K, Virchow JC Jr. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-15.
20. 20. Bradding P. Roberts JA, Britten KM, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-80.
21. 21. Zav'yalov VP, Denesyuk AI, White B, Yurovsky VV, Atamas SP, Korpela T. Molecular model of an alternative splice variant of human IL-4, 1L-4 delta 2, a naturally occurring inhibitor of IL-4-stimulated T cell proliferation. Immunol Lett 1997;58:149-52.
22. 22. Vener T, Nygren M, Andersson A, Uhlen M, Albert J, Lundeberg J. Use of multiple competitors for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1998;36:1864-70.
23. 23. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313-24.
24. 24. Kelly EA, Rodriguez RR, Busse WW, Jarjour NN. The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am J Respir Crit Care Med 1997;156:1421-8.
25. 25. Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
26. 26. Ying S, Durham SR, Jacobson MR, et al. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:200-6.
27. 27. Barata LT, Ying S, Meng Q, et al. IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Allergy Clin Immunol 1998;101:222-30.
28. 28. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35-42.
29. 29. Virchow JC Jr, Walker C, Hafner D, et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995;151:960-8.
30. 30. Robinson DS, Ying S, Bentley AM, et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993;92:397-403.